mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
4e-10 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
4e-10 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
0.34 |
5e-10 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
8e-10 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
1e-09 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
1e-08 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-08 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
1e-08 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-08 |
mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
0.3 |
2e-08 |